Clinical and outcome research in oncology. The need for integration

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  Apolone, Giovanni ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTOMATION; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG APPROVAL; DRUG EFFICACY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; EUROPE; EXPERIMENTAL DESIGN; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL TECHNOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SATISFACTION; PREDICTION; RELIABILITY; SELF REPORT; SOLID TUMOR; TREATMENT OUTCOME; CLINICAL TRIAL; EDITORIAL; MEDICAL RESEARCH; METHODOLOGY; NEOPLASM; ONCOLOGY; OUTCOME ASSESSMENT; QUALITY OF LIFE; UNITED STATES;

ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; EUROPE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 3142591867     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-3     Document Type: Article

References (18)

1. Bast RC, Mills GB and Young RC Translational research - traffic on the bridge Biomed Pharmacother 2001, 55:565-571
2. Nathan DG Careers in translational clinical research-Historical perspectives, future challenges JAMA 2002, 287:2424-2427
3. Piantadosi S Clinical Trials - A methodological perspective Wiley-Interscience Publication, John Wiley & Sons, Inc 1997,
4. Anderson C Measuring what works in health care Science 1994, 263:1080-1082
5. Epstein RS and Sherwood LM From outcome research to disease management: a guide for the perplexed Ann Intern Med 1996, 124:832-837
6. The outcomes of Cancer Outcomes Research Focussing on the National Cancer Institute's Quality-of-Care initiative Med Care 2002, 40(III):3-10
7. Lee SJ, Craig CE and Weeks JC Outcomes Research in oncology: history, conceptual framework, and trends in the literature JNCI 2000, 92:195-204
8. Redmond K Drug approval in the European Union Cancer Futures 2003, 1:53-54
9. McVie JG Are European cancer patients getting a fair deal? Ann Oncol 2002, 12:1033-1035
10. Garattini S and Bertelé V Adjusting Europe's drug regulation to public health needs Lancet 2001, 358:64-67
11. Garattini S and Bertelé V Efficacy, safety and cost of new anticancer drugs BMJ 2002, 325:269-271
12. Bottomley A and Therasse P Quality of life in patients undergoing systemic therapy for advanced breast cancer Lancet Oncol 2002, 3:620-628
13. Goodwin PJ, Black JT, Bordelau LJ and Ganz PA Health-Related quality of life measurement in randomised clinical trials in breast cancer-taking stock JNCI 2003, 95:263-281
14. Mosconi P, Fossati R, Confalonieri C and Apolone G Breast cancer and Quality of Life: Controversial points of view Tumori 2003, 2:S53-S54
15. Steer CB, Marx GM and Harper G Is there quality in clinical benefit? Ann Oncol 2001, 12:1191-1193
16. Apolone G and Mosconi P Review of the concept of quality of life assessment and discussion of the present trend in clinical research Nephrol Dial Transplant 1998, 13:65-69
17. Leplege A and Hunt s The problem of quality of life in medicine JAMA 1998, 278:47-50
18. Apolone G, De Carli G, Brunetti M and Garattini S An assessment of the EMEA recommendations on the use of HR-QOL measures in drug approval Pharmaco Economics 2001, 19:187-195